Human Continuum raises $5.1m to advance exosome platform (opens in new tab)

New funding will support development of regenerative therapies and diagnostics aimed at extending healthspan. A growing number of longevity companies are foreseeing that the future of medicine lies not only in treating disease, but in helping the body repair itself. Human Continuum is the latest to attract investor backing for that vision. The company announced […] The post appeared first on <a href="